Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors' Dealings notification transmitted by DGAP - a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. ------------------------------------------------------------------------------ Details of the person subject to the disclosure requirement Last name: Dr. Schulze First name: Frank Company: Biotest AG Position: Head of Microbiology Division Information about the transaction with duty of notification Description of the financial instrument: Preference Shares ISIN/WKN of the financial instrument: DE0005227235 Type of transaction: Buy Date: 15.05.2009 Price: 30.89 Currency: EUR No. of items: 650 Total amount traded: 20077.40 Place: Xetra, Stuttgart Explanation for publication: 20 Shares Quote 30,49/Share Xetra 120 Shares Quote 30,48/Share Xetra 510 Shares Quote 31,00/Share Stuttgart Information about the company with duty of publication Issuer: Biotest AG Landsteinerstraße 5 63303 Dreieich Deutschland ISIN: DE0005227235 WKN: 522723 End of Directors' Dealings Notification (c) DGAP 15.05.2009 Financial News transmitted by DGAP ID 9483
DGAP-DD: Biotest AG english
| Source: EQS Group AG